China Pharma News: Eisai/Bliss Biopharma USD 2 Billion…
The latest healthcare and life sciences news from China, including Eisai's USD 2 billion oncology deal with Bliss Biopharma; Hasten Biopharmaceutic…
See our Cookie Privacy Policy Here